Sweden
# |
Name |
Revenue Per Share |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 98.47
|
Dec. 31, 2023 | USD 13.60 | 0.68% |
|
Sweden |
|
2 |
USD 25.56
|
Dec. 31, 2023 | USD 11.83 | -0.07% |
|
Sweden |
|
3 |
USD 17.42
|
Dec. 31, 2023 | USD 9.89 | 0.86% |
|
Sweden |
|
4 |
USD 13.35
|
Dec. 31, 2023 | USD 27.53 | 0.68% |
|
Sweden |
|
5 |
USD 13.25
|
Dec. 31, 2023 | USD 6.50 | -2.66% |
|
Sweden |
|
6 |
USD 11.49
|
Dec. 31, 2023 | USD 9.64 | 1.81% |
|
Sweden |
|
7 |
USD 10.72
|
Dec. 31, 2023 | USD 1.60 | 7.23% |
|
Sweden |
|
8 |
USD 5.44
|
Dec. 31, 2023 | USD 31.10 | 0.68% |
|
Sweden |
|
9 |
USD 4.71
|
Dec. 31, 2023 | USD 2.88 | 0.37% |
|
Sweden |
|
10 |
USD 4.49
|
Dec. 31, 2023 | USD 0.30 | -1.64% |
|
Sweden |
|
11 |
USD 4.42
|
Dec. 31, 2023 | USD 3.03 | 4.68% |
|
Sweden |
|
12 |
USD 4.15
|
Dec. 31, 2023 | USD 0.53 | 1.01% |
|
Sweden |
|
13 |
USD 3.68
|
Dec. 31, 2023 | USD 1.76 | 0.42% |
|
Sweden |
|
14 |
USD 3.62
|
Dec. 31, 2023 | USD 0.77 | 2.33% |
|
Sweden |
|
15 |
USD 1.07
|
Dec. 31, 2023 | USD 0.69 | 3.06% |
|
Sweden |
|
16 |
USD 0.69
|
Dec. 31, 2023 | USD 0.39 | -2.44% |
|
Sweden |
|
17 |
USD 0.51
|
Dec. 31, 2023 | USD 0.75 | 3.75% |
|
Sweden |
|
18 |
USD 0.14
|
Dec. 31, 2023 | USD 0.96 | -2.22% |
|
Sweden |
|
19 |
USD 0.01
|
Dec. 31, 2023 | USD 0.90 | 9.88% |
|
Sweden |
The Research & Consulting company in Sweden with the highest Revenue Per Share is Ework Group AB (publ) (Stockholm Stock Exchange: EWRK.ST) at USD 98.47.
The Research & Consulting company in Sweden with the lowest Revenue Per Share is IRLAB Therapeutics AB (publ) (Stockholm Stock Exchange: IRLAB-A.ST) at USD 0.01.
The top 10 Research & Consulting companies in Sweden by Revenue Per Share are Ework Group AB (publ), Knowit AB (publ), Proact IT Group AB (publ), Byggmästare Anders J Ahlström Holding AB (publ), B3 Consulting Group AB (publ), Prevas AB, Wise Group AB (publ), Probi AB (publ), Ogunsen AB (publ) and Hedera Group AB (publ).
The bottom 10 Research & Consulting companies in Sweden by Revenue Per Share are IRLAB Therapeutics AB (publ), Cint Group AB (publ), Compodium International AB (publ), Brilliant Future AB (publ), Diadrom Holding AB (publ), Projektengagemang Sweden AB (publ), Nepa AB (publ), PION Group AB (publ), CombinedX AB (publ) and Hedera Group AB (publ).